Navigation Links
Ziehm Imaging Gets a New Sister Company
Date:9/27/2011

NUREMBERG, Germany, September 27, 2011 /PRNewswire/ --

Ziehm Imaging herewith announces that its holding company ATON GmbH acquired 100% of the US based leading Mini C-arm specialist OrthoScan, Inc. This acquisition shows ATON's continuous investment in the healthcare business with Ziehm Imaging being part of the ATON portfolio since 2004.

Klaus Hoerndler, CEO of Ziehm Imaging states: "We are sure that our partners value it as a positive signal around the world that further synergies are created for our customers, now that the two companies are held under one roof." Nelson Mendes, CEO of Ziehm Imaging Inc. comments that "this acquisition is a clear statement of ATON's commitment to the US market and the understanding of the US customer's needs."

Ziehm Imaging and OrthoScan product lines complement each other in the different surgical segments, allowing for close cooperation to jointly serve customers and open new business opportunities for both companies.

Press contact:

Ziehm Imaging
Martin Herzmann                        
Tel: +49 911 2172 0
Global Marketing Director                    
Fax: +49 911 2172 390
Martin.Herzmann@ziehm-eu.com                
http://www.ziehm.com



'/>"/>
SOURCE Ziehm Imaging
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
4. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
5. Stereo Mammography Takes Breast Imaging to a New Dimension
6. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
7. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
8. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
9. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
10. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
11. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):